Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K

Detalhes bibliográficos
Autor(a) principal: Luvizon, Aline Carbonera [UNESP]
Data de Publicação: 2014
Tipo de documento: Tese
Idioma: por
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://hdl.handle.net/11449/123271
http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/06-04-2015/000822183.pdf
Resumo: The relevance of estrogen in breast cancer development is well established in the literature. The use of E2 antagonists for ER-positive breast cancer treatment is shown to be important to patients´ survival. Amphiregulin, a multifunctional growth regulator factor that may be induced by estrogen plays a central role in development of mammary glands and organ morphogenesis, is expressed in both normal and cancerous tissues. Clinical studies suggest that amphiregulin also is important in human breast cancer progression and its expression has been associated with aggressive disease. To investigate the mechanism whereby E2 induces AREG expression, MCF-7 and MDA-MB-231 cells were treated for 10 minutes, 30 minutes, 1 hour or 4 hours with vehicle (control) or estrogen (E2) isolated or in association with Fulvestrant (ICI, estrogen receptor inhibitor), Actinomycin D (ACTD, gene transcription inhibitor), Cycloheximide (CHX, protein synthesis inhibitor ) or LY (PI3K inhibitor). The inhibitors were also used alone. mRNA was extracted from the cells by the Trizol method and AREG expression analyzed by qRT-PCR. Treatment of both cell types with E2 increased AREG mRNA expression at all moments. This increase was partially ER-dependent in MCF- 7 cells at 10 minutes, 1 and 4 hours. At 30 min, no binding of E2 to ER was obseved. In MDA-MB-231 cells, the estrogen-induced AREG mRNA was enhanced by two distinct pathways at the moments analyzed and PI3K pathways participated in one of them. Our results showed that E2 was able to induce the AREG expression in breast cancer cell lines in an ER-dependent and -independent manner
id UNSP_21ba054562761b882771bddd97c26bb0
oai_identifier_str oai:repositorio.unesp.br:11449/123271
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13KMamas - CancerEstrogêniosGlandulas mamariasEstrogenThe relevance of estrogen in breast cancer development is well established in the literature. The use of E2 antagonists for ER-positive breast cancer treatment is shown to be important to patients´ survival. Amphiregulin, a multifunctional growth regulator factor that may be induced by estrogen plays a central role in development of mammary glands and organ morphogenesis, is expressed in both normal and cancerous tissues. Clinical studies suggest that amphiregulin also is important in human breast cancer progression and its expression has been associated with aggressive disease. To investigate the mechanism whereby E2 induces AREG expression, MCF-7 and MDA-MB-231 cells were treated for 10 minutes, 30 minutes, 1 hour or 4 hours with vehicle (control) or estrogen (E2) isolated or in association with Fulvestrant (ICI, estrogen receptor inhibitor), Actinomycin D (ACTD, gene transcription inhibitor), Cycloheximide (CHX, protein synthesis inhibitor ) or LY (PI3K inhibitor). The inhibitors were also used alone. mRNA was extracted from the cells by the Trizol method and AREG expression analyzed by qRT-PCR. Treatment of both cell types with E2 increased AREG mRNA expression at all moments. This increase was partially ER-dependent in MCF- 7 cells at 10 minutes, 1 and 4 hours. At 30 min, no binding of E2 to ER was obseved. In MDA-MB-231 cells, the estrogen-induced AREG mRNA was enhanced by two distinct pathways at the moments analyzed and PI3K pathways participated in one of them. Our results showed that E2 was able to induce the AREG expression in breast cancer cell lines in an ER-dependent and -independent mannerA importância do estrógeno (E2) no desenvolvimento do câncer de mama é bem estabelecido na literatura. O uso de antagonistas de E2 para o tratamento de tumores positivos para o receptor de estrógeno mostra-se importante para a sobrevida de pacientes acometidas pela doença. Amphiregulin (Areg), um fator de crescimento regulador multifuncional que pode ser induzido por estrógeno, possui papel central no desenvolvimento da glândula mamária e na morfogênese de órgãos e é expresso tanto em tecidos normais como cancerosos. Estudos clínicos sugerem que amphiregulin também desempenha papel importante na progressão do câncer da mama humano e a sua expressão aumentada tem sido associada com doença agressiva. Para investigar o mecanismo pelo qual o E2 induz a expressão de AREG, células MCF-7 e MDA-MB-231 foram tratadas durante 10 minutos, 30 minutos, 1 hora e 4 horas com veículo (controle) ou E2 isoladamente ou em associação com Fulvestrant (ICI, inibidor do receptor de estrógeno), Actinomicina D (ACTD, inibidor da transcrição gênica), Ciclohexamida (CHX, inibidor da síntese proteica) ou LY (inibidor da via PI3K). Os inibidores também foram utilizados isoladamente. O RNAm foi extraído das células pelo método de trizol e a expressão de AREG foi analisada por qRT-PCR. O tratamento de ambas as células com E2 induziu aumento do RNAm de AREG em todos os tempos analisados. Esse aumento foi parcialmente dependente de ER nas células MCF-7 nos tempos de 10 minutos, 1 e 4 horas. Em 30 minutos não foi observado a ligação do E2 com o ER para que houvesse o aumento da expressão do gene alvo. Nas células MDA-MB-231 o estrógeno aumentou o RNAm de AREG por pelo menos duas vias distintas em todos tempos analisados. Uma das vias ativa a via PI3K para que este efeito ocorra. Nossos resultados demonstram que o E2 é capaz de induzir a expressão de AREG em linhagens de células de câncer de ...Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Universidade Estadual Paulista (Unesp)Fecchio, Denise [UNESP]Nogueira, Célia Regina [UNESP]Universidade Estadual Paulista (Unesp)Luvizon, Aline Carbonera [UNESP]2015-05-14T16:53:15Z2015-05-14T16:53:15Z2014-02-26info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesis46 f.application/pdfLUVIZON, Aline Carbonera. Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K. 2014. 46 f. Tese (doutorado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Medicina de Botucatu, 2014.http://hdl.handle.net/11449/123271000822183http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/06-04-2015/000822183.pdf33004064056P5Alephreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPporinfo:eu-repo/semantics/openAccess2024-01-02T06:16:34Zoai:repositorio.unesp.br:11449/123271Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-01-02T06:16:34Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K
title Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K
spellingShingle Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K
Luvizon, Aline Carbonera [UNESP]
Mamas - Cancer
Estrogênios
Glandulas mamarias
Estrogen
title_short Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K
title_full Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K
title_fullStr Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K
title_full_unstemmed Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K
title_sort Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K
author Luvizon, Aline Carbonera [UNESP]
author_facet Luvizon, Aline Carbonera [UNESP]
author_role author
dc.contributor.none.fl_str_mv Fecchio, Denise [UNESP]
Nogueira, Célia Regina [UNESP]
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Luvizon, Aline Carbonera [UNESP]
dc.subject.por.fl_str_mv Mamas - Cancer
Estrogênios
Glandulas mamarias
Estrogen
topic Mamas - Cancer
Estrogênios
Glandulas mamarias
Estrogen
description The relevance of estrogen in breast cancer development is well established in the literature. The use of E2 antagonists for ER-positive breast cancer treatment is shown to be important to patients´ survival. Amphiregulin, a multifunctional growth regulator factor that may be induced by estrogen plays a central role in development of mammary glands and organ morphogenesis, is expressed in both normal and cancerous tissues. Clinical studies suggest that amphiregulin also is important in human breast cancer progression and its expression has been associated with aggressive disease. To investigate the mechanism whereby E2 induces AREG expression, MCF-7 and MDA-MB-231 cells were treated for 10 minutes, 30 minutes, 1 hour or 4 hours with vehicle (control) or estrogen (E2) isolated or in association with Fulvestrant (ICI, estrogen receptor inhibitor), Actinomycin D (ACTD, gene transcription inhibitor), Cycloheximide (CHX, protein synthesis inhibitor ) or LY (PI3K inhibitor). The inhibitors were also used alone. mRNA was extracted from the cells by the Trizol method and AREG expression analyzed by qRT-PCR. Treatment of both cell types with E2 increased AREG mRNA expression at all moments. This increase was partially ER-dependent in MCF- 7 cells at 10 minutes, 1 and 4 hours. At 30 min, no binding of E2 to ER was obseved. In MDA-MB-231 cells, the estrogen-induced AREG mRNA was enhanced by two distinct pathways at the moments analyzed and PI3K pathways participated in one of them. Our results showed that E2 was able to induce the AREG expression in breast cancer cell lines in an ER-dependent and -independent manner
publishDate 2014
dc.date.none.fl_str_mv 2014-02-26
2015-05-14T16:53:15Z
2015-05-14T16:53:15Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv LUVIZON, Aline Carbonera. Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K. 2014. 46 f. Tese (doutorado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Medicina de Botucatu, 2014.
http://hdl.handle.net/11449/123271
000822183
http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/06-04-2015/000822183.pdf
33004064056P5
identifier_str_mv LUVIZON, Aline Carbonera. Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K. 2014. 46 f. Tese (doutorado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Medicina de Botucatu, 2014.
000822183
33004064056P5
url http://hdl.handle.net/11449/123271
http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/06-04-2015/000822183.pdf
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 46 f.
application/pdf
dc.publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
dc.source.none.fl_str_mv Aleph
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1803047221697970176